These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 30166860)
1. Abnormal expression of Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation. Yan XD; Yao M; Wang L; Zhang HJ; Yan MJ; Gu X; Shi Y; Chen J; Dong ZZ; Yao DF World J Gastroenterol; 2013 Sep; 19(36):6084-92. PubMed ID: 24106410 [TBL] [Abstract][Full Text] [Related]
3. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286 [TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089 [No Abstract] [Full Text] [Related]
5. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer. Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein. Wang LK; Xie XN; Song XH; Su T; Chang XL; Xu M; Liang B; Huang DY Technol Cancer Res Treat; 2018 Jan; 17():1533033818806475. PubMed ID: 30343649 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma. Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells. Guo S; Wang Y; Gao Y; Zhang Y; Chen M; Xu M; Hu L; Jing Y; Jing F; Li C; Wang Q; Zhu Z Med Sci Monit; 2016 Oct; 22():3951-3960. PubMed ID: 27774979 [TBL] [Abstract][Full Text] [Related]
9. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor. Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374 [TBL] [Abstract][Full Text] [Related]
10. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma. Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573 [TBL] [Abstract][Full Text] [Related]
11. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation. Sai WL; Yao M; Shen SJ; Zheng WJ; Sun JY; Wu MN; Wang L; Yao DF Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):449-454. PubMed ID: 32171652 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/β-catenin signaling. Xie X; Pan J; Han X; Chen W Chem Biol Interact; 2019 Feb; 300():73-81. PubMed ID: 30639441 [TBL] [Abstract][Full Text] [Related]
13. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo. Yao M; Wang L; Yang J; Yan X; Cai Y; Yao D Tumour Biol; 2016 Nov; 37(11):14677-14686. PubMed ID: 27623941 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms. Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest. Fan J; Lou B; Chen W; Zhang J; Lin S; Lv FF; Chen Y Tumour Biol; 2014 Nov; 35(11):11523-32. PubMed ID: 25129440 [TBL] [Abstract][Full Text] [Related]
16. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype. Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759 [TBL] [Abstract][Full Text] [Related]
17. Translocated HMGB3 is involved in papillary thyroid cancer progression by activating cytoplasmic TLR3 and transmembrane TREM1. Zhao Y; Lv HJ; Deng XY; Chen P; Garstka MA; Shi BY; Fu J Cell Cycle; 2023; 22(23-24):2584-2601. PubMed ID: 38197217 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients. Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer. Fang J; Ge X; Xu W; Xie J; Qin Z; Shi L; Yin W; Bian M; Wang H J Cell Physiol; 2020 Apr; 235(4):3438-3446. PubMed ID: 31621076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]